Form 4: Bio-Rad Laboratories Executive Acquires Restricted Stock Units

Courtney C. Enloe, EVP, General Counsel & Secretary of Bio-Rad Laboratories, acquired 3,072 restricted stock units on September 6, 2024.

Summary

• On September 6, 2024, Courtney C. Enloe, EVP, General Counsel & Secretary of Bio-Rad Laboratories, acquired 3,072 restricted stock units.
• The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
• Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
• Following the transaction, Enloe directly owns 3,072 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing an executive's acquisition of restricted stock units. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of restricted stock units aligns the executive's interests with those of the shareholders.

Future Outlook

The restricted stock units vest over four years, suggesting a long-term commitment from the executive.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of restricted stock units aligns the executive's interests with those of the shareholders, potentially incentivizing performance.

Key Dates